share_log

HC Wainwright & Co. Maintains Buy on ORIC Pharmaceuticals, Raises Price Target to $21

Moomoo 24/7 ·  Mar 21 06:15

HC Wainwright & Co. analyst Robert Burns maintains ORIC Pharmaceuticals (NASDAQ:ORIC) with a Buy and raises the price target from $15 to $21.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment